Optimal Pharmacologic Strategy for TCAR: An Expert Panel Discussion
With Michael R. Jaff, DO; Sumaira Macdonald, MBChB (Comm), MD, FRCP, FRCR, PhD; Richard Cambria, MD; Nathan J. Aranson, MD; Angela A. Kokkosis, MD; Herbert D. Aronow, MD, MPH; and Edgar D. Guzman, MD, FACS, RPVI
